EHA-HSB Haematology Tutorial 2025, Dhaka

Exchanging Experiences: Overcoming Challenges Together

Dear colleagues,

It is our great pleasure to invite you to the EHA-HSB Haematology Tutorial 2025, Dhaka – an educational event focused primarily on malignant haematology.

This tutorial will offer an interactive learning experience, concentrating on challenges faced by hematologists in developing countries with resource-poor facilities.

The field of malignant haematological disorders is progressing rapidly in both diagnostic and therapeutic perspectives. Developing countries continue working to adopt world-class management protocols.

The proposed eight sessions on haematological malignancies will feature lectures by renowned EHA experts alongside case presentations by Bangladeshi speakers. Through presentations and discussions, attendees will learn cutting-edge management approaches from standard facilities, as well as solutions experts in developing countries employ to overcome constraints.

A wide range of complex real-life cases and topics have been selected to address diverse interests within malignant haematology. Each session will include audience questions, self-assessment, and panel discussions.

The EHA-HSB Haematology Tutorial 2025, Dhaka is designed exclusively for haematologists, paediatric haematologist-oncologists, haematopathologists, and transfusion medicine specialists involved in managing haematological conditions.

Whether you are an above-mentioned specialist or a senior Bangladeshi trainee in haematology, you will benefit from in-depth case discussions, interactive sessions, and the latest evidence-based recommendations.

This is primarily an in-person event. Interested specialists from outside Bangladesh may participate virtually.

Warm regards,
EHA & HSB Organizing Committee

Renowned Speakers from EHA

Daniel Molin, MD, PhD

Oncology Consultant, Uppsala University Hospital

An expert in lymphomas with a special focus on Hodgkin lymphomas. He is the head of the clinical lymphoma group at Uppsala University Hospital and chair of the Swedish Lymphoma Group.

Gianluca Gaidano, MD, PhD

Professor of Hematology, University of Eastern Piedmont

His research focuses on the precision medicine of lymphoid malignancies, non-Hodgkin lymphoma, and CLL. He is a recipient of the EHA Education and Mentorship Award.

Priyanka Mehta

Consultant Haematologist, University Hospitals Bristol and Weston NHS Trust

Her clinical and research interests are in myeloid malignancies, with a focus on acute myeloid leukaemia (AML). She is leading the development of the first UK AML Registry.

Shahram Kordasti

Reader in Applied Cancer Immunopathology, King’s College London

A clinical haematologist with an interest in MDS, AA, and myeloproliferative neoplasms. His research focuses on the immunobiology of myeloid malignancies and the role of CD4+ T cells.

Program at a Glance

EHA is joining the Haematology Society of Bangladesh (HSB) to organize the EHA-HSB Haematology Tutorial 2025, Dhaka on updates on diagnosis and management of haematological malignancies.

Date: October 3–4, 2025
Location: Dhaka, Bangladesh
Format: Hybrid (Virtual only for participants from abroad)

Goal of the Meeting

This EHA-led Haematology Tutorial focuses on “Updates on Diagnosis and Management of Haematological Malignancies.” It aims to deepen the knowledge of haematology trainees and fellows in the diagnosis and management of lymphoid and myeloid malignancies; explore recent innovations and developments; and foster collaboration with local and international experts to advance haematology care and research in the region.

Target Audience

Haematologists
Haematopathologists
Paediatric haematologist-oncologists
Transfusion medicine specialists
Senior students of Haematology

Topics That Will Be Covered

Use of molecular technologies for diagnosis and monitoring of haematological malignancies
Novel agents and autologous transplant in the management of treatment-resistant T & B cell lymphomas
Updated management of Hodgkin Lymphoma
Management of treatment-resistant or relapsed acute myeloid leukemia
Current management of relapsed Acute Lymphoblastic Leukemia
Updates in the management of thalassemia
Modern therapy for Multiple Myeloma and Chronic Lymphocytic Leukemia
Updates on cellular therapy: Application of ASCT and CAR-T cell therapy

The preliminary program will be available on the meeting program page.

Learning Objectives

Gain enhanced ability to diagnose and manage myeloid and lymphoid malignancies, including common B-cell and T/NK-cell lymphomas, Hodgkin lymphoma, and acute/chronic leukemia in both frontline and relapse settings using updated strategies
Improve decision-making in selecting appropriate treatment options—novel agents, immunotherapy, or BMT—based on disease biology and patient profile

Organizers

European Hematology Association (EHA)

EHA is a leading force in hematology worldwide, bringing the community together to share knowledge, collaborate, connect, and grow. Together with other societies, EHA accelerates progress through education, science, and innovation to improve patient outcomes and advance toward cures—across Europe and beyond.

Guided by the belief that hematology research, education, and treatment are shared resources, EHA envisions transforming the future of hematology in Europe and globally. These resources should be accessible to everyone, wherever they are in the world.

EHA’s primary goal is to mobilize the community, share knowledge, and align interests to advocate for hematology by empowering progress, knowledge, and partnerships.

Haematology Society of Bangladesh (HSB)

The Haematology Society of Bangladesh is the representative organization and voice for all the haematologists in Bangladesh. The country's healthcare system has achieved significant progress since independence in 1971, and is rapidly advancing toward international standards.

Nevertheless, a large segment of the population remains beyond reach of standard haematology care due to poverty, lack of public awareness, and inadequate education facilities. The Haematology Society of Bangladesh was established to raise public awareness about the nature, prevalence, prevention, and management of hematological disorders in Bangladesh; to foster unity among the nation's hematologists; to protect members' professional interests and dignity.

The society is committed to serving as a platform for delivering haematology and related disorder treatments; advancing medical education to international standards; providing resources, knowledge, and initiatives for doctors, healthcare providers, and the public regarding haematology.

A key aim of HSB is to establish collaborative partnerships with national and international organizations in the field of haematology. To achieve this objective, HSB regularly conducts public awareness campaigns and educational programs in collaboration with various domestic and international partners.

InterContinental Dhaka

The official venue for EHA-HSB Haematology Tutorial 2025, offering a premium experience for all attendees.

Where Is It?

Intercontinental Dhaka,
1 Minto Road, Ramna, Dhaka, Bangladesh

Event Date

Saturday, October 03, 2025
Full-day conference & activities

Our Valued Sponsors

Empowering Haematology Education & Innovation

EHA-HSB Haematology Tutorial 2025, Dhaka acknowledges the generous support of our sponsors. Their dedication helps us deliver an exceptional learning experience and shape a healthier future.

Event Starts In